167 related articles for article (PubMed ID: 28687351)
1. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.
Lloyd TE; Christopher-Stine L; Pinal-Fernandez I; Tiniakou E; Petri M; Baer A; Danoff SK; Pak K; Casciola-Rosen LA; Mammen AL
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):66-71. PubMed ID: 25892010
[TBL] [Abstract][Full Text] [Related]
3. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
Herbert MK; Stammen-Vogelzangs J; Verbeek MM; Rietveld A; Lundberg IE; Chinoy H; Lamb JA; Cooper RG; Roberts M; Badrising UA; De Bleecker JL; Machado PM; Hanna MG; Plestilova L; Vencovsky J; van Engelen BG; Pruijn GJ
Ann Rheum Dis; 2016 Apr; 75(4):696-701. PubMed ID: 25714931
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
5. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
Yeker RM; Pinal-Fernandez I; Kishi T; Pak K; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2018 May; 77(5):714-719. PubMed ID: 29363513
[TBL] [Abstract][Full Text] [Related]
6. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
[TBL] [Abstract][Full Text] [Related]
7. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.
Goyal NA; Cash TM; Alam U; Enam S; Tierney P; Araujo N; Mozaffar FH; Pestronk A; Mozaffar T
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):373-8. PubMed ID: 25857661
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis.
Kramp SL; Karayev D; Shen G; Metzger AL; Morris RI; Karayev E; Lam Y; Kazdan RM; Pruijn GJ; Saschenbrecker S; Dähnrich C; Schlumberger W
Auto Immun Highlights; 2016 Dec; 7(1):16. PubMed ID: 27858337
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ
Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448
[TBL] [Abstract][Full Text] [Related]
10. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
Seelig CA; Bauer O; Seelig HP
Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
13. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis.
Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y
Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.
Zhang YM; Yang HB; Shi JL; Chen H; Shu XM; Lu X; Wang GC; Peng QL
Clin Rheumatol; 2018 Jun; 37(6):1573-1580. PubMed ID: 29541951
[TBL] [Abstract][Full Text] [Related]
16. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Muro Y; Sugiura K; Morita Y; Tomita Y
Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
[TBL] [Abstract][Full Text] [Related]
17. Novel serology testing for sporadic inclusion body myositis: disease-specificity and diagnostic utility.
Herbert MK; Pruijn GJ
Curr Opin Rheumatol; 2015 Nov; 27(6):595-600. PubMed ID: 26285103
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
19. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
20. A study of anti-carbonic anhydrase II antibodies in rheumatic autoimmune diseases.
Ono M; Ono M; Watanabe K; Miyashita Y; Inagaki Y; Ueki H
J Dermatol Sci; 1999 Nov; 21(3):183-6. PubMed ID: 10527380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
